Scots scientists 'train' AI to assess cancer in revolutionary system
SCOTLAND has the world’s highest incidence of the “asbestos cancer” mesothelioma and now artificial intelligence (AI) is being used to assess patients in a system that could revolutionise how they are cared for. Canon Medical Research Europe, a Scottish firm specialising in next generation medical imaging software, and the University of Glasgow are set to publish clinical findings from a study evaluating a new, world-leading AI-driven cancer assessment tool, developed as part of the Cancer Innovation Challenge. The study team, comprising AI and data scientists at Canon Medical and U...